[Combined use of anti-tachycardia pacemaker and internal cardiovertor for the control of recurrent ventricular tachycardia].
Ventricular tachycardia may be a serious complication of different forms of heart disease. It usually develops in later stages of the disease, with poor ventricular function and may lead to sudden death. Antiarrhythmic drug therapy is frequently unsuccessful. We report our experience with the first patient receiving an internal cardiovertor-defibrillator and anti-tachycardia pacemaker for treatment of drug refractory ventricular tachycardia. After 3 months of follow-up the patient is back to work with good tolerance to both devices.
González
R
R
Departamento de Enfermedades Cardiovasculares, Pontificia Universidad Católica de Chile, Santiago.
Casanegra
P
P
D004554:Electric Countershock / Q000295:instrumentation; D006801:Humans; D008297:Male; D008875:Middle Aged; D010138:Pacemaker, Artificial; D011379:Prognosis; D013610:Tachycardia / Q000503:physiopathology / Q000628:therapy*; D014693:Ventricular Fibrillation / Q000503:physiopathology / Q000628:therapy*
Uso combinado de marcapaso antitaquicardia y de cardiovertor interno para el control de la taquicardia ventricular recurrente.